INM Earnings InMed Pharmaceuticals Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q3 2026 | 2026-03-31 | -1.69 | 2026-05-06 | 10-Q |
| Q2 2026 | 2025-12-31 | -0.95 | 2026-02-11 | 10-Q |
| Q1 2026 | 2025-09-30 | -0.44 | 2025-11-06 | 10-Q |
| FY 2025 | 2025-06-30 | -8.36 | 2025-09-23 | 10-K |
| Q3 2026 | 2025-03-31 | -7.93 | 2026-05-06 | 10-Q |
| Q2 2026 | 2024-12-31 | -6.43 | 2026-02-11 | 10-Q |
| Q1 2026 | 2024-09-30 | -2.71 | 2025-11-06 | 10-Q |
| FY 2025 | 2024-06-30 | -20.14 | 2025-09-23 | 10-K |
| Q3 2025 | 2024-03-31 | -16.48 | 2025-05-12 | 10-Q |
| Q2 2025 | 2023-12-31 | -14.21 | 2025-02-12 | 10-Q |
| Q1 2025 | 2023-09-30 | -15.24 | 2024-11-14 | 10-Q |
| FY 2024 | 2023-06-30 | -3.25 | 2024-09-30 | 10-K |
| Q3 2023 | 2023-03-31 | -3.53 | 2023-05-15 | 10-Q |
| Q2 2024 | 2022-12-31 | -3.54 | 2024-02-13 | 10-Q |
| Q1 2024 | 2022-09-30 | -4.06 | 2023-11-14 | 10-Q |
| FY 2023 | 2022-06-30 | -33.17 | 2023-09-29 | 10-K |
| Q3 2023 | 2022-03-31 | -20.13 | 2023-05-15 | 10-Q |
| Q2 2023 | 2021-12-31 | -14.03 | 2023-02-17 | 10-Q |
| Q1 2023 | 2021-09-30 | -6.17 | 2022-11-14 | 10-Q |
| FY 2022 | 2021-06-30 | -37.96 | 2022-09-23 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.